We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App

Innovative Technology Detects Early-Stage Breast Cancer in Two Minutes

By MedImaging International staff writers
Posted on 04 Dec 2023
Print article
Image: The innovative technology is cheaper and safer than common cancer diagnostic tools (Photo courtesy of University of Waterloo)
Image: The innovative technology is cheaper and safer than common cancer diagnostic tools (Photo courtesy of University of Waterloo)

Breast cancer is the second-most common cancer and among the second-leading causes of death from cancer for women. The sooner a malignant tumor is detected, the higher the chances of survival in breast cancer patients. Now, researchers are at the forefront of developing a groundbreaking method for early breast cancer detection, which holds the promise of being both more accurate and cost-effective than current diagnostic approaches like X-ray mammography, ultrasound, and MRI. This new technology, which has already completed test runs in just two minutes using less energy than a smartphone, offers a safer alternative to X-rays by avoiding high-level radiation exposure that can potentially damage DNA and lead to cancer.

Since 2001, researchers at University of Waterloo (Waterloo, ON, Canada) have been delving into the use of low-frequency electromagnetic waves for detecting early-stage breast cancer. Their significant discovery that these waves travel in straight lines has led to the development of a disruptive diagnostic device. This device, resembling X-ray mammography but without its limitations, employs low-frequency electromagnetic energy emitted from an antenna similar to those in smartphones. This energy, upon penetrating the breast, is captured by a metasurface or circuit board composed of interconnected pixels, with each pixel functioning as a receiver.

An AI system processes the data from the circuit board, eliminating the need for manual review by a technician. This advanced technology is capable of pinpointing a tumor's size and location, effectively detecting abnormalities even in dense breast tissue, an area where current diagnostics often fall short. The effectiveness of this system has been validated through tests on breast phantoms, artificial structures that mimic the properties of human breasts. The research team is now focused on advancing this technology for human trials and developing a prototype suitable for mass production. Their ultimate objective is to make this innovative diagnostic tool affordable and accessible globally, similar to the ease and frequency of in-pharmacy blood pressure tests.

“We are coming very close to providing a method for breast cancer detection at an early stage that is inexpensive and harmless for women,” said Dr. Omar Ramahi, lead researcher and a professor in Waterloo’s Department of Electrical and Computer Engineering. “We’re trying to make a serious contribution to women’s health and create an alternative that is clinically and commercially viable.”

Related Links:
University of Waterloo

Gold Member
Solid State Kv/Dose Multi-Sensor
Remote Controlled Digital Radiography and Fluoroscopy System
Eco Track-DRF - MARS 50/MARS50+/MARS 65/MARS 80
Breast Imaging Workstation
Ultrasound System
P20 Elite

Print article



view channel
Image: The device creates microbubbles that temporarily disrupt the BBB, permitting the entry of immunotherapy into the brain (Photo courtesy of Northwestern)

Ultrasound Technology Breaks Blood-Brain Barrier for Glioblastoma Treatment

Despite extensive molecular studies, the outlook for patients diagnosed with the aggressive brain cancer known as glioblastoma (GBM) continues to be poor. This is partly due to the blood-brain barrier... Read more

Nuclear Medicine

view channel
Image: 68Ga-NC-BCH whole-body PET imaging rapidly targets an important gastrointestinal cancer biomarker in lesions in GI cancer patients (Photo courtesy of Qi, Guo, et al.; doi.org/10.2967/jnumed.123.267110)

New PET Radiotracer Enables Same-Day Imaging of Key Gastrointestinal Cancer Biomarker

Gastrointestinal cancers rank among the most prevalent cancers worldwide, contributing to over a quarter of all cancer cases and over one-third of cancer-related deaths annually. The initial symptoms of... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.